Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
50 /100
MEDIUM RISK
Score updated Oct 13, 2026

ADCT — ADC Therapeutics SA Dilution Risk Tracker

Track ADCT dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ADCT — Get alerts when the score changes →

As of October 13, 2026, ADC Therapeutics SA (ADCT) has a DilutionWatch DilutionScore of 50/100, rated MEDIUM dilution risk. ADC Therapeutics SA has a market capitalization of $237.46M, 127.67M shares outstanding, 118 institutional holders tracked. Stored dilution-related fields include shelf registration capacity of $37.50M, ATM program capacity of $37.50M.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
66
💰 Cash Runway
25
📊 Float Risk
17
⚠️ Warrant Exposure
40
🔄 Convertible Debt
15

Dilution Forecast

⛅
Watch
Minor dilution signals detected
model est. 19%
💰 Capital Raise model 38%
• Active shelf registration ($38M, 16% of market cap)
• Active ATM program with $38M remaining capacity
🔔 Track ADCT — Get forecast alerts →

Market Data

Market Cap$237.46M
Shares Outstanding127.67M
Float100.41M
Cash$219.11M
Debt$6.18M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore50/100DilutionWatch score record
Shares Outstanding127.67MVerified float table or market cache
Public Float100.41MVerified float table or market cache
Market Cap$237.46MMarket data cache
Cash Runway18.1 monthsDilutionWatch score inputs
Shelf Capacity$37.50MSEC-derived dilution fields
ATM Capacity$37.50MSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 7.

Recent SEC source mix: 4 1, 424B3 2, EFFECT 1, S-3 1, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 10.6% shares (2026Q1 vs prior)
118 institutional holders · 94.20M shares
#1 Redmile Group, LLC 15.47M shares
#2 TCG Crossover Management, LLC 11.39M shares
#3 MORGAN STANLEY 11.25M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest6.90M
Days to Cover4.4
% of Float6.9%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-08-13
xbrl XBRL CONVERTIBLE 2026-03-10
424B3 ATM 2026-04-15
4 INSIDER TRANSACTION 2026-04-02
424B3 ATM 2026-03-16
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual ADCT Dilution Snapshot

ADC Therapeutics SA (ADCT) has a DilutionScore of 50/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

ADCT's DilutionScore is currently 50/100 (Medium risk), with 3 score changes tracked over 89 days. The score deteriorated from 56/100 (High risk).

Period Score Risk Level Duration
Sep 30 – Oct 13, 202650/100MEDIUM14 days
Aug 22 – Sep 29, 202656/100HIGH39 days
Aug 14 – Aug 21, 202663/100HIGH7 days
Jul 16 – Aug 13, 202656/100HIGH29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

ADCT shares outstanding have increased 2.7% from 123.88M (Mar 2026) to 127.19M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 07, 2026127.19M100.41M▼ 17.48%
May 06, 2026127.19M121.69M▲ 21.33%
May 02, 2026127.19M100.30M▲ 1.34%
Apr 26, 2026127.19M98.97M▲ 0.03%
Apr 20, 2026127.04M98.94M▼ 1.91%
Mar 13, 2026123.88M100.86M▼ 15.05%
Mar 12, 2026123.88M118.73M▲ 21.54%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track ADCT Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment ADCT files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking ADCT — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for ADCT
ADCT FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.